Tci Wealth Advisors, Inc. Prometheus Biosciences, Inc. Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$103.46 - $126.29 $6,311 - $7,703	61 Added 93.85%	126 $13,000
Q4 2022 Feb 06, 2023	BUY	$36.06 - $117.21 $2,343 - $7,618	65 New	65 $7,000
Q2 2022 Jul 19, 2022	SELL	$22.39 - $38.94 $2,977 - $5,179	-133 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$30.13 - $50.0 $4,007 - $6,650	133 New	133 $5,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.